Adalimumab provides long-lasting clinical improvement in refractory mucocutaneous Behcet's disease without formation of antidrug antibodies

Authors
Publication date
1 January 2019
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    EUR Research Repository

    redirect
    oaioai:pure.eur.nl:publications/b...
    Last time updated on 29/05/2023